全文获取类型
收费全文 | 2031篇 |
免费 | 204篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 36篇 |
妇产科学 | 27篇 |
基础医学 | 287篇 |
口腔科学 | 18篇 |
临床医学 | 214篇 |
内科学 | 349篇 |
皮肤病学 | 36篇 |
神经病学 | 92篇 |
特种医学 | 182篇 |
外科学 | 258篇 |
综合类 | 58篇 |
一般理论 | 1篇 |
预防医学 | 248篇 |
眼科学 | 157篇 |
药学 | 99篇 |
中国医学 | 3篇 |
肿瘤学 | 176篇 |
出版年
2022年 | 13篇 |
2021年 | 27篇 |
2020年 | 14篇 |
2019年 | 29篇 |
2018年 | 52篇 |
2017年 | 36篇 |
2016年 | 43篇 |
2015年 | 45篇 |
2014年 | 69篇 |
2013年 | 99篇 |
2012年 | 116篇 |
2011年 | 113篇 |
2010年 | 56篇 |
2009年 | 64篇 |
2008年 | 115篇 |
2007年 | 103篇 |
2006年 | 107篇 |
2005年 | 110篇 |
2004年 | 98篇 |
2003年 | 114篇 |
2002年 | 103篇 |
2001年 | 45篇 |
2000年 | 26篇 |
1999年 | 34篇 |
1998年 | 43篇 |
1997年 | 23篇 |
1996年 | 20篇 |
1995年 | 22篇 |
1994年 | 24篇 |
1993年 | 21篇 |
1992年 | 21篇 |
1991年 | 13篇 |
1990年 | 17篇 |
1989年 | 14篇 |
1988年 | 16篇 |
1987年 | 19篇 |
1986年 | 13篇 |
1984年 | 15篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1980年 | 14篇 |
1979年 | 18篇 |
1978年 | 15篇 |
1977年 | 15篇 |
1975年 | 13篇 |
1974年 | 12篇 |
1948年 | 11篇 |
1947年 | 13篇 |
1946年 | 16篇 |
1945年 | 14篇 |
排序方式: 共有2243条查询结果,搜索用时 15 毫秒
991.
Liverton NJ Bednar RA Bednar B Butcher JW Claiborne CF Claremon DA Cunningham M DiLella AG Gaul SL Libby BE Lyle EA Lynch JJ McCauley JA Mosser SD Nguyen KT Stump GL Sun H Wang H Yergey J Koblan KS 《Journal of medicinal chemistry》2007,50(4):807-819
The discovery of a novel series of NR2B subtype selective N-methyl-d-aspartate (NMDA) antagonists is reported. Initial optimization of a high-throughput screening lead afforded an aminopyridine derivative 13 with significant NR2B antagonist potency but limited selectivity over hERG-channel and other off-target activities. Further structure-activity studies on the aminoheterocycle moiety and optimization of the carbamate led to the highly potent 2-aminopyrimidine derivative 20j with a significantly improved off-target activity profile and oral bioavailability in multiple species coupled with good brain penetration. Compound 20j demonstrated efficacy in in vivo rodent models of antinociception, allodynia, and Parkinson's disease. 相似文献
992.
993.
de Simone G Olsen MH Wachtell K Hille DA Dahlöf B Ibsen H Kjeldsen SE Lyle PA Devereux RB 《Journal of human hypertension》2007,21(8):625-632
The relation of metabolic syndrome (MetS) with cardiovascular outcome may be less evident when preclinical cardiovascular disease is present. We explored, in a post hoc analysis, whether MetS predicts cardiovascular events in hypertensive patients with electrocardiographic left ventricular hypertrophy (ECG-LVH) in the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study. MetS was defined by >or=2 risk factors plus hypertension: body mass index >or=30 kg/m(2), high-density lipoprotein (HDL)-cholesterol <1.0/1.3 mmol/l (<40/50 mg/dl) (men/women), glucose >or=6.1 mmol/l (>or=110 mg/dl) fasting or >or=7.8 mmol/l (>or=140 mg/dl) nonfasting or diabetes. Cardiovascular death and the primary composite end point (CEP) of cardiovascular death, stroke and myocardial infarction were examined. In MetS (1,591 (19.3%) of 8,243 eligible patients), low HDL-cholesterol (72%), obesity (77%) and impaired glucose (73%) were similarly prevalent, with higher blood pressure, serum creatinine and Cornell product, but lower Sokolow-Lyon voltage (all P<0.001). After adjusting for baseline covariates, hazard ratios for CEPs and cardiovascular death (4.8+/-1.1 years follow-up) were 1.47 (95% confidence interval (CI), 1.27-1.71)- and 1.73 (95% CI, 1.38-2.17)-fold higher with MetS (both P<0.0001), and were only marginally reduced when further adjusted for diabetes, obesity, low HDL-cholesterol, non-HDL-cholesterol, pulse pressure and in-treatment systolic blood pressure and heart rate. Thus, MetS is associated with increased cardiovascular events in hypertensive patients with ECG-LVH, independently of single cardiovascular risk factors. 相似文献
994.
Mishra RK Kizer JR Palmieri V Roman MJ Galloway JM Fabsitz RR Lee ET Best LG Devereux RB 《Echocardiography (Mount Kisco, N.Y.)》2007,24(4):340-347
INTRODUCTION: The myocardial performance index (MPI) introduced by Tei, a Doppler-derived echocardiographic measure that reflects both left ventricular (LV) systolic and diastolic function, has been shown to have prognostic value in several clinical settings, including myocardial infarction and congestive heart failure. There are scant data on the correlates and prognostic value of MPI in a population without overt cardiovascular (CV) disease. METHODS: We investigated clinical and physiologic correlates of MPI, as assessed from echocardiographic Doppler recordings in 1,862 American Indian participants free of coronary or valvular disease or LV systolic dysfunction in the population-based strong heart study (SHS). We then assessed the prognostic value of MPI for incident CV events, including nonfatal stroke, coronary heart disease, congestive heart failure, and CV death. RESULTS: The study population was 59 +/- 8 years old (66% women); 48% had diabetes, 44% hypertension, and 54% were obese. In univariable analyses, MPI (mean = 0.24 +/- 0.17) showed significant negative associations with creatinine clearance, C-reactive protein (CRP), LV ejection fraction (EF), mitral valve E- and A-wave velocities, cardiac index (CI), stroke index (SI) and stroke index/pulse pressure (SI/PP), and significant positive associations with serum creatinine and total peripheral resistance index (TPRI) (all P < 0.05). There were no significant associations of MPI with hypertension or diabetes status, systolic or diastolic blood pressure, body mass index, hemoglobin A1C or LV mass. After adjusting for age, sex, diabetes, and hypertension, MPI remained weakly but significantly correlated with CRP, EF, CI, SI, SI/PP, mitral E- and A-wave velocities, and TPRI. MPI did not predict fatal and nonfatal CV events (risk ratio 1.06 per unit MPI, 95% C.I. 0.56-2.04; P = 0.85) at a mean follow-up of 7.1 +/- 2.2 years. CONCLUSIONS: In a population-based sample of adults with high prevalence of diabetes, hypertension, and obesity but without overt CV disease, MPI has weak associations with clinical and physiologic determinants of cardiac function. Moreover, MPI does not provide prognostic information for CV events in this population. Though conceptually attractive as a global measure of cardiac function, MPI has limited utility in a high-risk population without clinical CV disease. 相似文献
995.
996.
Delatycki MB Wolthuizen M Collins V Varley E Craven J Allen KJ Gurrin LC Aitken M Trembath MK Bond L Wilson GR Stephenson SE Macciocca I Hickerton C Lockhart PJ Metcalfe SA 《European journal of human genetics : EJHG》2012,20(5):505-509
As the results of the Human Genome Project are realised, screening for genetic mutations that predispose to preventable disease is becoming increasingly possible. How and where such screening should best be offered are critical, unanswered questions. This study aimed to assess the acceptability and feasibility of genetic screening for preventable disease, using the model of hereditary haemochromatosis, in high-school students. Screening was offered for the HFE C282Y substitution to 17,638 students. Questionnaires were administered at the time of screening (Q1) and approximately 1 month after results were communicated (Q2). Outcomes assessed were uptake of screening, change in scores of validated anxiety, affect and health perception scales from Q1 to Q2, knowledge and iron indices in C282Y homozygous individuals. A total of 5757 (32.6%) students had screening and 28 C282Y-homozygous individuals (1 in 206) were identified, and none of the 27 individuals who had iron indices measures had significant iron overload. There was no significant change in measures of anxiety, affect or health perception in C282Y homozygous or non-homozygous individuals. Over 86% of students answered each of five knowledge questions correctly at Q1. Genetic population-based screening for a preventable disease can be offered in schools in a way that results in minimal morbidity for those identified at high risk of disease. The results of this study are not only relevant for haemochromatosis, but for other genetic markers of preventable disease such as those for cardiovascular disease and cancer. 相似文献
997.
Leidenroth A Sorte HS Gilfillan G Ehrlich M Lyle R Hewitt JE 《European journal of human genetics : EJHG》2012,20(9):999-1003
We studied and validated facioscapulohumeral muscular dystrophy (FSHD) samples from patients without a D4Z4 contraction (FSHD2 or 'phenotypic FSHD'). For this, we developed non-radioactive protocols to test D4Z4 allele constitution and DNA methylation, and applied these to samples from the Coriell Institute Cell Repository. The D4Z4 sizing showed two related subjects to have classic chromosome 4 contraction-dependent FSHD1. A third sample (GM17726) did not have a short chromosome 4 fragment, and had been assigned as non-4q FSHD (FSHD2). We tested D4Z4 haplotype and methylation for this individual but found both to be inconsistent with this diagnosis. Using exome sequencing, we identified two known pathogenic mutations in CAPN3 (Arg490Gln and Thr184Argfs(*)36), indicating a case of LGMD2A rather than FSHD. Our study shows how a wrong diagnosis can easily be corrected by whole-exome sequencing by constraining the variant analysis to candidate genes after the data have been generated. This new way of 'diagnosis by sequencing' is likely to become common place in genetic diagnostic laboratories. We also publish a digoxigenin-labeled Southern protocol to test D4Z4 methylation. Our data supports hypomethylation as a good epigenetic predictor for FSHD2. The non-radioactive protocol will help to make this assay more accessible to clinical diagnostic laboratories and the wider FSHD research community. 相似文献
998.
Selmer KK Gilfillan GD Strømme P Lyle R Hughes T Hjorthaug HS Brandal K Nakken S Misceo D Egeland T Munthe LA Braekken SK Undlien DE 《European journal of human genetics : EJHG》2012,20(1):58-63
Next-generation sequencing (NGS) techniques have already shown their potential in the identification of mutations underlying rare inherited disorders. We report here the application of linkage analysis in combination with targeted DNA capture and NGS to a Norwegian family affected by an undiagnosed mental retardation disorder with an autosomal recessive inheritance pattern. Linkage analysis identified two loci on chromosomes 9 and 17 which were subject to target enrichment by hybridization to a custom microarray. NGS achieved 20-fold or greater sequence coverage of 83% of all protein-coding exons in the target regions. This led to the identification of compound heterozygous mutations in NAGLU, compatible with the diagnosis of Mucopolysaccharidosis IIIB (MPS IIIB or Sanfilippo Syndrome type B). This diagnosis was confirmed by demonstrating elevated levels of heparan sulphate in urine and low activity of α-N-acetyl-glucosaminidase in cultured fibroblasts. Our findings describe a mild form of MPS IIIB and illustrate the diagnostic potential of targeted NGS in Mendelian disease with unknown aetiology. 相似文献
999.
Jiang Y Cowley SA Siler U Melguizo D Tilgner K Browne C Dewilton A Przyborski S Saretzki G James WS Seger RA Reichenbach J Lako M Armstrong L 《Stem cells (Dayton, Ohio)》2012,30(4):599-611
Chronic granulomatous disease (CGD) is an inherited disorder of phagocytes in which NADPH oxidase is defective in generating reactive oxygen species. In this study, we reprogrammed three normal unrelated patient's fibroblasts (p47(phox) and gp91(phox) ) to pluripotency by lentiviral transduction with defined pluripotency factors. These induced pluripotent stem cells (iPSC) share the morphological features of human embryonic stem cells, express the key pluripotency factors, and possess high telomerase activity. Furthermore, all the iPSC lines formed embryoid bodies in vitro containing cells originating from all three germ layers and were capable of teratoma formation in vivo. They were isogenic with the original patient fibroblasts, exhibited normal karyotype, and retained the p47(phox) or gp91(pho) (x) mutations found in the patient fibroblasts. We further demonstrated that these iPSC could be differentiated into monocytes and macrophages with a similar cytokine profile to blood-derived macrophages under resting conditions. Most importantly, CGD-patient-specific iPSC-derived macrophages showed normal phagocytic properties but lacked reactive oxygen species production, which correlates with clinical diagnosis of CGD in the patients. Together these results suggest that CGD-patient-specific iPSC lines represent an important tool for modeling CGD disease phenotypes, screening candidate drugs, and the development of gene therapy. 相似文献
1000.
Armstrong L 《Stem cell reviews》2012,8(1):67-77
Pluripotent embryonic stem cells can give rise to almost all somatic cell types but this characteristic requires precise control
of their gene expression patterns. The necessity of keeping the entire genome “poised” to enter into any of a number of developmental
possibilities requires a unique and highly plastic chromatin organisation based around specific patterns of histone modifications
although this state of affairs is normally short lived during embryonic development. By deriving embryonic stem cells from
the early embryo, we can preserve the highly specialised genome organisation and this has permitted several detailed investigations
into the molecular basis of pluripotency. 相似文献